Randomized Trial of Electronic Cigarettes With or Without Nicotine in Smoking Cessation.
Key facts
- Who runs it
- Assistance Publique - Hôpitaux de Paris
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- Phase
- Phase 3
- People taking part
- 650 people, planned
- Started
- 17 Oct 2018
- Expected to end
- Dec 2029
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Electronic cigarette without nicotine (ECwN) plus active varenicline tablets
- Electronic cigarette without nicotine (ECwoN) plus placebo tablets of varenicline
- Electronic cigarette with nicotine (ECwN) plus placebo tablets of varenicline
- Record updated
- 29 December 2025
Who can take part
- Age
- 18 years to 70 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (22)Hide the full registry criteria
Who can take part
- Smokers smoking at least 10 cigarettes/day (factory made or roll-your-own) in the past year
- Aged 18 to 70 years
- Motivated to quit defined as a score > 5 on a visual rating scale ranging from 0 (not motivated at all) to 10 (extremely motivated)
- Signed written informed consent
- Understanding and speaking French
- Women of childbearing age can be included if they use an effective contraceptive method: either hormonal contraception or an intrauterine device started at least one month before the first research visit
- Individual affiliated to a health insurance system as defined by the sponsor (except Aide Médicale d'État =AME)
- Previous failure of nicotine replacement therapy for smoking cessation
Who cannot take part
- abuse of or dependence on illegal drugs in the last 6 months revealed by the medical history
- current or previous (last 6 months) use of electronic cigarette
- current or past (last 3 months) use of smoking cessation medication such as varenicline, bupropion, nicotine replacement therapies
- any unstable disease condition within the last 3 months defined by the investigator as major change in symptoms or treatments such as 1.1.recent myocardial infarction, 1.2.unstable or worsening angina 1.3.severe cardiac arrhythmia 1.4.unstable or uncontrolled arterial hypertension 1.5.recent stroke 1.6.cerebrovascular disease 1.7.obliterative peripheral arterial disease 1.8.cardiac insufficiency 1.9.diabetes 1.10.hyperthyroidism 1.11.pheochromocytoma 1.12.severe hepatic insufficiency 1.13.history of seizures 1.14.severe depression 1.15.chronic obstructive pulmonary disease (COPD)
- any life threatening condition with life-expectancy of less than 3 months
- alcohol use disorder defined as a score ≥ 10 on the AUDIT-C questionnaire
- hypersensitivity to the active substance or to any of the excipients
- known severe renal failure
- regular use of tobacco products other than cigarettes
- pregnant women
- breastfeeding women
- protected adults
- current or past 3 months participation in another interventional research
- known lactose intolerance (placebo tablets contain lactose)
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Background:
Read full original descriptionShow less
Electronic cigarettes (EC) mainly containing nicotine (88-95 % of users) are widely and growingly used worldwide. It is estimated that there were 1.7 million daily users in France in 2016. Although the number of publications about its use is increasing exponentially, there are no evidence based, unbiased, head-to-head comparison data about its efficacy as an aid to smoking cessation. As of today, only two head-to-head randomized studies have been published, both reported negative results at the main endpoint but they used first and second generation EC delivering nicotine with low or unknown bioavailability. Recent EC deliver nicotine with largely improved bioavailability.
One of the randomized studies compared EC with and without nicotine to nicotine patch and reported similar smoking cessation rate at main outcome. However, there is no published, double blind study comparing EC use with a well-studied, licensed smoking cessation medication.
Superiority of EC with nicotine compared to EC without nicotine and to a reference smoking cessation medication while collecting also straightforward information about safety, would allow proposing EC with nicotine to the large population of smokers who intend to quit and situate it among the approved smoking cessation treatments.
The clinical study's hypothesis:
EC containing nicotine can be considered as a nicotine replacement therapy having, probably, a better bioavailability of nicotine than the marketed pharmaceutical NRTs, first line medications of smoking cessation. It is therefore of interest to compare EC containing nicotine to EC without nicotine but also to a reference medication with demonstrated efficacy in smoking cessation. We hypothesize that EC with nicotine provides a higher smoking abstinence rate than EC without nicotine and may be as good as varenicline, our reference medication.
The 3 groups in the trial
- Electronic cigarette conditionTreatment being tested
Electronic cigarette with nicotine (ECwN) plus placebo tablets of varenicline
Treatment: Electronic cigarette with nicotine (ECwN) plus placebo tablets of varenicline
- Varenicline conditionExisting treatment, for comparison
Reference group: Electronic cigarette without nicotine (ECwoN) plus active varenicline tablets
Treatment: Electronic cigarette without nicotine (ECwN) plus active varenicline tablets
- Placebo conditionPlacebo, for comparison
Electronic cigarette without nicotine (ECwoN) plus placebo tablets of varenicline
Treatment: Electronic cigarette without nicotine (ECwoN) plus placebo tablets of varenicline
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Randomized, Placebo Controlled, Double Blind, Double Dummy, Multicenter Trial Comparing Electronic Cigarettes With Nicotine to Varenicline and to Electronic Cigarettes Without Nicotine.
- Publications
- Record updated
- 29 December 2025